Atlas Trials

An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects

Clinical trial NCT01848340 · COMPLETED

Trial details

NCT number
NCT01848340
Sponsor
ViiV Healthcare
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV-associated Lipodystrophy Syndrome
Start date
2013-05-01
Primary completion
2013-07-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.